Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the In Situ Hybridization Market Size Changed, over the years?

In recent times, the in situ hybridization market has seen substantial growth. The market is predicted to expand from $1.68 billion in 2024 to $1.83 billion in 2025, indicating a Compound Annual Growth Rate (CAGR) of 8.9%. This growth observed in the historic period is the result of several factors including early adoption in research, advancements in molecular biology tools, the growth of diagnostic applications, a shift in focus within biomedical research, and an increase in biotechnology investments.

How Much Will the In Situ Hybridization Market Be Worth in 2029?

The market size for in situ hybridization is projected to expand considerably in the coming years, reaching a value of “$2.79 billion in 2029 with a compound annual growth rate (CAGR) of 11.2%. The surge during the forecasted period can be linked to its growing use in clinical diagnostics, increased funding for research and development, and the advent of automation and high-throughput solutions. Its broader applications in neuroscience and pathology also contribute to this growth. The anticipated trends within this forecasted timeframe encompass advances in molecular biology, increased demand in research applications, expansion in diagnostic applications, a growing demand for personalized medicine, and a rise in investment for biomedical research.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10476&type=smp

Which is the Largest Company in the In Situ Hybridization Market?

Major companies operating in the in situ hybridization market include Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Abnova Corporation, Qiagen, Bio-Techne Corporation, Biochain Institute Inc., Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, FISH Technologies Sdn Bhd, Genetix Biotech Asia Pvt. Ltd., Zytomed System GmbH, Akoya Biosciences Inc., Becton Dickinson and Company (BD), DAKO Systemtechnik und Service GmbH & Co, Molecular Devices LLC., NanoString Technologies Inc., Visiopharm A/S

What Are the Main Market Drivers in the In Situ Hybridization Industry?

A rise in infectious diseases is predicted to boost the development of the in-situ hybridization market. Infectious illnesses, which can be transmitted from one person to another through contaminated food, drink and pathogens such as viruses, bacteria, fungi, and parasites, are indicated here. In-situ hybridization (ISH) uses labeled nucleic acid sequences (probes) specific to the infectious agent, to identify matching nucleic acid sequences found in the tissue. Therefore, a surge in infectious diseases enhances the expansion of the in-situ hybridization market. For example, the Centers for Disease Control and Prevention, a government agency based in the US, reported an increase in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, an increase of 1,295 cases in March 2024. Therefore, it can be stated that the escalating incidence of infectious diseases is contributing to the growth of the in-situ hybridization market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10476&type=smp

How Is the In Situ Hybridization Market Segments Structured?

The in situ hybridization market covered in this report is segmented –

1) By Product: Analytical Instruments, Kits and Reagents, Software and Services, Other Products

2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ hybridization (CISH)

3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)

4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases, Other Applications

5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes, Other End Uses

Subsegments:

1) By Analytical Instruments: Fluorescence Microscopes, Imaging Systems, Hybridization Systems

2) By Kits and Reagents: Hybridization Kits, Detection Kits, Probes And Reagents

3) By Software and Services: Image Analysis Software, Data Management Software, Consulting And Support Services

4) By Other Products: Accessories, Control Samples, Maintenance Supplies

What Strategic Trends Are Transforming the In Situ Hybridization Market?

Leading firms in the in situ hybridization market are investing in the creation of innovative solutions like RNA detection assays to bolster the progress of gene therapy. RNA detection assays are molecular methods that aid in the recognition and quantification of distinct RNA molecules within a sample, facilitating research into gene expression, viral infections, and more. For example, Bio-Techne Corporation, a US-based life sciences firm, unveiled the RNAscope Plus smRNA-RNA detection assay in January 2023. This is a sophisticated in situ hybridization instrument that enables simultaneous fluorescent detection of small regulatory RNAs, such as microRNAs (miRNAs), and three target RNAs or RNA biomarkers within the same tissue section. The assay provides a single-cell and subcellular resolution, enabling scientists to efficiently examine the biodistribution and functionality of novel gene therapies and endogenous regulatory RNAs. This assay has been designed for large-scale studies and can be used on the Leica Bond Rx platform or as a manual assay. The assay, which combines proprietary RNAscope and miRNAscope technologies, greatly enhances comprehension of gene expression and cellular responses, providing crucial insights into the development of personalized gene therapies for inherited or acquired diseases.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report

Which Global Regions Offer the Highest Growth in the In Situ Hybridization Market?

North America was the largest region in the in situ hybridization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10476

This Report Delivers Insight On:

1. How big is the in situ hybridization market, and how is it changing globally?

2. Who are the major companies in the in situ hybridization market, and how are they performing?

3. What are the key opportunities and risks in the in situ hybridization market right now?

4. Which products or customer segments are growing the most in the in situ hybridization market?

5. What factors are helping or slowing down the growth of the in situ hybridization market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model